Loading…
Holographic Health, Inc. was warned for marketing 13 dietary supplement products as unapproved drugs by making disease claims on their website without proper FDA authorization. The company violated the Federal Food, Drug, and Cosmetic Act by claiming their products could regulate blood sugar, treat pancreatic issues, reduce inflammation, and treat celiac disease—statements that established the products as drugs under FDA regulations rather than dietary supplements. These marketing claims for products including Glyco-Well, Pan-Gest, Heart-Line, and others indicated intent to cure, mitigate, or treat diseases, which requires FDA approval before the products can be legally sold.